- Home
- Publications
- Publication Search
- Publication Details
Title
Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 15, Pages 5436
Publisher
MDPI AG
Online
2020-07-31
DOI
10.3390/ijms21155436
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pumping the brakes on RAS – negative regulators and death effectors of RAS
- (2020) Desmond R. Harrell Stewart et al. JOURNAL OF CELL SCIENCE
- Mortalin/HSPA9 targeting selectively induces KRAS tumor cell death by perturbing mitochondrial membrane permeability
- (2020) Pui-Kei Wu et al. ONCOGENE
- Mortalin (HSPA9) facilitates BRAF-mutant tumor cell survival by suppressing ANT3-mediated mitochondrial membrane permeability
- (2020) Pui-Kei Wu et al. Science Signaling
- Targeting Alterations in the RAF–MEK Pathway
- (2019) Rona Yaeger et al. Cancer Discovery
- Mortalin (GRP75/HSPA9) Promotes Survival and Proliferation of Thyroid Carcinoma Cells
- (2019) Dmytro Starenki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Comprehensive Analysis of ERK1/2 Substrates for Potential Combination Immunotherapies
- (2019) Lei Yang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A Convergence-Based Framework for Cancer Drug Resistance
- (2018) David J. Konieczkowski et al. CANCER CELL
- A cellular threshold for active ERK1/2 levels determines Raf/MEK/ERK-mediated growth arrest versus death responses
- (2018) Seung-Keun Hong et al. CELLULAR SIGNALLING
- DA-Raf, a dominant-negative antagonist of the Ras–ERK pathway, is a putative tumor suppressor
- (2018) Emiri Kanno et al. EXPERIMENTAL CELL RESEARCH
- ERK1/2 inhibitors: New weapons to inhibit the RAS-regulated RAF-MEK1/2-ERK1/2 pathway
- (2018) Andrew M. Kidger et al. PHARMACOLOGY & THERAPEUTICS
- Hyperactivation of MAPK Signaling is Deleterious to RAS/RAF Mutant Melanoma
- (2018) Grace P Leung et al. MOLECULAR CANCER RESEARCH
- Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells
- (2018) Arun M Unni et al. eLife
- A compendium of ERK targets
- (2017) Evrim B. Ünal et al. FEBS LETTERS
- Steady-State Levels of Phosphorylated Mitogen-Activated Protein Kinase Kinase 1/2 Determined by Mortalin/HSPA9 and Protein Phosphatase 1 Alpha in KRAS and BRAF Tumor Cells
- (2017) Pui-Kei Wu et al. MOLECULAR AND CELLULAR BIOLOGY
- Cancer drug addiction is relayed by an ERK2-dependent phenotype switch
- (2017) Xiangjun Kong et al. NATURE
- A Braf kinase-inactive mutant induces lung adenocarcinoma
- (2017) Patricia Nieto et al. NATURE
- Differential localization of A-Raf regulates MST2-mediated apoptosis during epithelial differentiation
- (2016) J Rauch et al. CELL DEATH AND DIFFERENTIATION
- Single-cell dynamics and variability of MAPK activity in a yeast differentiation pathway
- (2016) Patrick Conlon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ERK1 and ERK2 present functional redundancy in tetrapods despite higher evolution rate of ERK1
- (2015) Roser Buscà et al. BMC EVOLUTIONARY BIOLOGY
- Tunable-Combinatorial Mechanisms of Acquired Resistance Limit the Efficacy of BRAF/MEK Cotargeting but Result in Melanoma Drug Addiction
- (2015) Gatien Moriceau et al. CANCER CELL
- ERK1/2 can feedback-regulate cellular MEK1/2 levels
- (2015) Seung-Keun Hong et al. CELLULAR SIGNALLING
- Sp1 regulates Raf/MEK/ERK-induced p21CIP1 transcription in TP53-mutated cancer cells
- (2015) Mansi Karkhanis et al. CELLULAR SIGNALLING
- Active ERK2 is sufficient to mediate growth arrest and differentiation signaling
- (2015) Pui-Kei Wu et al. FEBS Journal
- MEK1/2 Inhibitors: Molecular Activity and Resistance Mechanisms
- (2015) Pui-Kei Wu et al. SEMINARS IN ONCOLOGY
- ERK Mutations Confer Resistance to Mitogen-Activated Protein Kinase Pathway Inhibitors
- (2014) E. M. Goetz et al. CANCER RESEARCH
- Protein interaction switches coordinate Raf-1 and MST2/Hippo signalling
- (2014) David Romano et al. NATURE CELL BIOLOGY
- Targeting RAS–ERK signalling in cancer: promises and challenges
- (2014) Ahmed A. Samatar et al. NATURE REVIEWS DRUG DISCOVERY
- Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells
- (2014) D Starenki et al. ONCOGENE
- Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation
- (2013) X. Deschenes-Simard et al. GENES & DEVELOPMENT
- MEK1/2 Overactivation Can Promote Growth Arrest by Mediating ERK1/2-Dependent Phosphorylation of p70S6K
- (2013) Jean-Philippe Guégan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- A Mortalin/HSPA9-Mediated Switch in Tumor-Suppressive Signaling of Raf/MEK/Extracellular Signal-Regulated Kinase
- (2013) P.-K. Wu et al. MOLECULAR AND CELLULAR BIOLOGY
- Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
- (2013) Meghna Das Thakur et al. NATURE
- ERK2 Suppresses Self-Renewal Capacity of Embryonic Stem Cells, but Is Not Required for Multi-Lineage Commitment
- (2013) William B. Hamilton et al. PLoS One
- ERK1/2 MAP kinases: Structure, function, and regulation
- (2012) Robert Roskoski PHARMACOLOGICAL RESEARCH
- ERK1 Regulates the Hematopoietic Stem Cell Niches
- (2012) Nathalie Saulnier et al. PLoS One
- Importance of Domain Closure for the Autoactivation of ERK2
- (2011) Daniel Barr et al. BIOCHEMISTRY
- Examining Docking Interactions on ERK2 with Modular Peptide Substrates
- (2011) Sunbae Lee et al. BIOCHEMISTRY
- Pancreatitis-Induced Inflammation Contributes to Pancreatic Cancer by Inhibiting Oncogene-Induced Senescence
- (2011) Carmen Guerra et al. CANCER CELL
- c-Myc Regulates RNA Splicing of the A-Raf Kinase and Its Activation of the ERK Pathway
- (2011) J. Rauch et al. CANCER RESEARCH
- Post-transcriptional regulation of the Ras-ERK/MAPK signaling pathway
- (2011) Jarrett T. Whelan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Working Without Kinase Activity: Phosphotransfer-Independent Functions of Extracellular Signal-Regulated Kinases
- (2011) J. Rodriguez et al. Science Signaling
- BRAF Inactivation Drives Aneuploidy by Deregulating CRAF
- (2010) T. Kamata et al. CANCER RESEARCH
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
- (2010) Sonja J. Heidorn et al. CELL
- How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?
- (2010) Yohannes Mebratu et al. CELL CYCLE
- Jailbreak: Oncogene-induced senescence and its evasion
- (2010) Fiona K.E. MDuff et al. CELLULAR SIGNALLING
- Induction of Autophagy and Inhibition of Melanoma Growth In Vitro and In Vivo by Hyperactivation of Oncogenic BRAF
- (2010) Nityanand Maddodi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
- (2010) Poulikos I. Poulikakos et al. NATURE
- Post-transcriptional regulation of MEK-1 by polyamines through the RNA-binding protein HuR modulating intestinal epithelial apoptosis
- (2009) Peng-Yuan Wang et al. BIOCHEMICAL JOURNAL
- RASSF1A Mediates p21Cip1/Waf1-Dependent Cell Cycle Arrest and Senescence through Modulation of the Raf-MEK-ERK Pathway and Inhibition of Akt
- (2009) S. Thaler et al. CANCER RESEARCH
- Selective Role for Mek1 but not Mek2 in the Induction of Epidermal Neoplasia
- (2009) F. A. Scholl et al. CANCER RESEARCH
- Map2k1 and Map2k2 genes contribute to the normal development of syncytiotrophoblasts during placentation
- (2009) V. Nadeau et al. DEVELOPMENT
- ERK and cell death: ERK1/2 in neuronal death
- (2009) Srinivasa Subramaniam et al. FEBS Journal
- ERK and cell death: Mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence
- (2009) Sebastien Cagnol et al. FEBS Journal
- KSR1 Is Required for Cell Cycle Reinitiation Following DNA Damage
- (2009) Gina L. Razidlo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Noncatalytic Function of ERK1/2 Can Promote Raf/MEK/ERK-mediated Growth Arrest Signaling
- (2009) Seung-Keun Hong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors
- (2008) Laure Voisin et al. BMC CANCER
- PEA-15 Induces Autophagy in Human Ovarian Cancer Cells and Is Associated with Prolonged Overall Survival
- (2008) C. Bartholomeusz et al. CANCER RESEARCH
- Protein scaffolds in MAP kinase signalling
- (2008) Matthew D. Brown et al. CELLULAR SIGNALLING
- Many roads lead to oncogene-induced senescence
- (2008) S Courtois-Cox et al. ONCOGENE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now